Summary & Overview
CPT 86971: Enzymatic Red Cell Treatment for Antibody and Compatibility Testing
CPT code 86971 covers an enzymatic treatment of red blood cells performed in the immunohematology laboratory to prepare cells for antibody screening and compatibility testing. This preparatory step can affect downstream transfusion testing and has operational significance across hospital blood banks and independent clinical laboratories nationwide. The code is relevant for payers and clinical laboratories managing pretransfusion workflows and for policy discussions on laboratory service classification and coverage.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the procedure, typical sites of service, and the role this service plays in transfusion safety and antibody detection. The publication also provides benchmarking context, common modifier usage, and notes on billing practice where available. If specific payer policy or coverage determinations are not included, those details are noted as not available in the input.
This report is intended to inform billing staff, laboratory managers, and policy analysts about the clinical intent of CPT code 86971, how it fits into pretransfusion testing workflows, and the types of topics—coverage, coding nuances, and clinical context—that are important when evaluating reimbursement and operational impact nationally.
Billing Code Overview
CPT code 86971 describes a laboratory procedure in which a lab analyst incubates red blood cells (RBCs) with an enzyme to modify the red cell surface in preparation for subsequent immunohematology testing. This enzymatic treatment is performed to facilitate or enhance downstream procedures such as RBC antibody screening and compatibility (crossmatch) testing.
-
Service type: Immunohematology laboratory procedure (enzymatic red cell treatment)
-
Typical site of service: Hospital or independent clinical laboratory, blood bank, or transfusion service where pretransfusion testing and antibody investigation are performed.
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and detailed service line.
Clinical & Coding Specifications
Clinical Context
A typical patient is a hospitalized adult or outpatient requiring pre-transfusion testing or antibody investigation. A phlebotomy specimen is drawn and sent to the hospital or reference immunohematology laboratory. The laboratory technologist performs enzyme treatment of reagent or patient red blood cells to enhance or expose blood group antigens for an RBC antibody screen, identification, or compatibility testing. The workflow: specimen accessioning, cell wash and preparation, incubation of red blood cells with enzyme reagent per protocol (e.g., ficin or papain), washing, then subsequent performance of antibody screen, panel, or crossmatch using the enzyme-treated cells. Results guide transfusion compatibility decisions or further immunohematology workup for patients with prior transfusions, pregnancy, hemolytic anemia, or suspected alloantibody formation. Typical sites of service include hospital core laboratories, outpatient reference immunohematology laboratories, and transfusion medicine departments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional component of a lab service if applicable to lab-physician interpretive work (rare for this assay). |
59 |